These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9058847)
1. Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination. Grant AO Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):432-44. PubMed ID: 9058847 [TBL] [Abstract][Full Text] [Related]
2. [Ion channels and arrhythmias]. Borchard U; Hafner D Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780 [TBL] [Abstract][Full Text] [Related]
3. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study. Cimponeriu A; Starmer CF; Bezerianos A IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030 [TBL] [Abstract][Full Text] [Related]
4. Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking. Harkcom WT; Abbott GW Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1161-73. PubMed ID: 20670193 [TBL] [Abstract][Full Text] [Related]
5. The cardiac ion channels: relevance to management of arrhythmias. Roden DM; George AL Annu Rev Med; 1996; 47():135-48. PubMed ID: 8712768 [TBL] [Abstract][Full Text] [Related]
6. Proarrhythmic and antiarrhythmic actions of ion channel blockers on arrhythmias in the heart: model study. Chay TR Am J Physiol; 1996 Jul; 271(1 Pt 2):H329-56. PubMed ID: 8760192 [TBL] [Abstract][Full Text] [Related]
7. Modernized Classification of Cardiac Antiarrhythmic Drugs. Lei M; Wu L; Terrar DA; Huang CL Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657 [TBL] [Abstract][Full Text] [Related]
8. Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past--perspectives of the future. Varro A; Nanasi PP; Acsai K; Virag L; Papp JG Curr Pharm Des; 2004; 10(20):2411-27. PubMed ID: 15320753 [TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmics--from cell to clinic: past, present, and future. Hancox JC; Patel KC; Jones JV Heart; 2000 Jul; 84(1):14-24. PubMed ID: 10862579 [No Abstract] [Full Text] [Related]
10. Antiarrhythmic drugs and ion channels: have we made the connection? Carmeliet E J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931 [No Abstract] [Full Text] [Related]
11. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates. Roden DM Am J Cardiol; 1996 Aug; 78(4A):12-6. PubMed ID: 8780324 [TBL] [Abstract][Full Text] [Related]
12. Preventing unfolded protein response-induced ion channel dysregulation to treat arrhythmias. Liu M; Kang GJ; Dudley SC Trends Mol Med; 2022 Jun; 28(6):443-451. PubMed ID: 35414478 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic and therapeutic perspectives for cardiac arrhythmias: beyond ion channels. Wu Y; Li J; Xu L; Lin L; Chen YH Sci China Life Sci; 2017 Apr; 60(4):348-355. PubMed ID: 28349303 [TBL] [Abstract][Full Text] [Related]
17. Model systems for the discovery and development of antiarrhythmic drugs. Nattel S; Duker G; Carlsson L Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282 [TBL] [Abstract][Full Text] [Related]
18. Novel targets for cardiac antiarrhythmic drug development. Hesketh JC; Herrera D; Zicha S; Nattel S Curr Pharm Des; 2005; 11(15):1959-74. PubMed ID: 15974970 [TBL] [Abstract][Full Text] [Related]
19. [Ionic mechanisms of action of class III antiarrhythmic drugs]. Kuz'min VS; Rozenshtraukh LV Kardiologiia; 2010; 50(7):49-61. PubMed ID: 20659045 [TBL] [Abstract][Full Text] [Related]
20. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias]. Lipnitskiĭ TN; Kozlovskiĭ VA Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]